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Few studies have been able to contrast associations of anxiety and depression with heart 
disease. These disorders can be grouped in fear and distress disorders. Aim of this study was 
to study the association between fear and distress disorders with subsequent heart disease, 
taking into account the temporal order of disorders. 
Methods 
Twenty household surveys were conducted in 18 countries (n=53791;person 
years=2,212,430). The Composite International Diagnostic Interview assessed lifetime 
prevalence and age at onset of disorders, and respondents were categorized into categories 
based on the presence and timing of fear and distress disorders. Heart disease was indicated 
by self-report of physician-diagnosed heart disease or self-report of heart attack, together with 
year of onset. Survival analyses estimated associations between disorder categories and heart 
disease. 
Results 
Most respondents with fear or distress disorders had either pure distress or pure fear (8.5% 
and 7.7% of total sample), while fear preceded distress in the large majority of respondents 
with comorbid fear and distress (3.8% of total sample). Compared to the “no fear or distress 
disorder” category, respondents with pure fear disorder had the highest odds of subsequent 
heart disease (OR:1.8;95%CI:1.5-2.2;p<.001) and compared to respondents with pure distress 
disorder, these respondents were at a significantly increased risk of heart disease 
(OR:1.3;95%CI:1.0-1.6;p=0.020).  
Conclusion 
This novel analytic approach indicates that the risk of subsequent self-reported heart disease 
associated with pure fear disorder is significantly larger than the risk associated with distress 
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disorder. These results should be confirmed in prospective studies using objective measures of 
heart disease. 




Most attention to the association between psychosocial factors and heart disease has been 
directed to depression, with several meta-analyses showing that depression is related to an 
increased risk of coronary heart disease (CHD) (Nicholson et al., 2006; Van der Kooy et al., 
2007). Several studies showed that anxiety is also related to the development of CHD, which 
was confirmed in a first meta-analysis on this topic (Roest et al., 2010). Most anxiety studies 
have focused on elevated symptoms of anxiety. However, generalized anxiety disorder (GAD) 
was related to subsequent cardiovascular and all-cause mortality in Vietnam veterans, 
although after adjustment for covariates the association remained statistically significant for 
all-cause mortality only (Phillips et al., 2009). Posttraumatic stress disorder (PTSD) has also 
been shown to increase the risk of CHD and heart disease mortality in Vietnam veterans 
(Boscarino 2008; Vaccarino et al., 2013). In addition, a recent systematic review and meta-
analysis summarizing results of studies with varied study designs, found a significant 
association between panic disorder (PD) and incident CHD (Tully et al., 2015a). Indeed 
anxiety disorders might even be more strongly related to the development of CHD than 
depression. Early onset anxiety disorder, but not depressive disorder, predicted the 
development of CHD in young Swedish men over a period of 37 years (Janszky et al., 2010). 
Also, in the World Mental Health (WMH) Surveys, the risk of subsequent heart disease was 
stronger for PD, specific phobia, and PTSD than for depression after adjustment for mental 
disorder comorbidity (Scott et al., 2013), although it was not tested whether this difference 
between anxiety disorders and depression was statistically significant.  
Depressive and anxiety disorders have a considerable overlap (Clark & Watson 1991; Watson 
2005). In an empirically based model, Watson grouped anxiety and depressive disorders into 
fear and distress disorder categories since these groups appear to be distinctly different from 
each other (Watson 2005), a distinction that has subsequently been empirically confirmed 
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(Kessler et al., 2012a; Eaton et al., 2013). In this model, fear disorders (panic disorder, 
agoraphobia without panic, social anxiety disorder (SAD), specific phobia) are distinguished 
from distress disorders (depression, dysthymia, and GAD). In this model GAD is classified as 
a distress disorder since it is more strongly linked to depression than to fear disorders, which 
are characterized by phobic fear and somatic arousal (Clark & Watson 1991; Watson 2005; 
Brown & McNiff 2009; Den Hollander-Gijsman et al., 2010). Phobic fear and somatic arousal 
may be particularly strongly related to the development of heart disease and adverse prognosis 
in patients with CHD (Albert et al., 2005; Watkins et al., 2010; Nabi et al., 2010; Roest et al., 
2014). Therefore, categorizing depressive and anxiety disorders into fear and distress 
disorders may be more useful than comparing anxiety and depressive disorders, or examining 
all disorders separately, when investigating the association between these disorders and heart 
disease.   
Few studies have considered the role of anxiety disorders when examining the association 
between depressive disorder and heart disease and none have examined whether fear disorders 
explain the association between distress disorders and development of heart disease. The 
median age of onset of fear disorders is much earlier than for distress disorders, especially for 
specific phobia and SAD (Kessler et al., 2005). Also, traumatic life experiences, which can 
lead to PTSD, often occur for the first time in childhood/adolescence (Kessler et al., 2012b). 
In addition to occurring at an earlier age, fear disorders also have a more persistent course 
than distress disorders, and fear disorders, especially phobias and panic, may even predict the 
first onset of a distress disorder (Wittchen et al., 2003; Mathew et al., 2011; Kessler et al., 
2012a). These characteristics of fear disorders give rise to the possibility that the association 
with subsequent heart disease is stronger for fear disorders than for distress disorders since 
anxious individuals would experience a more long-term exposure to mediating mechanisms. 
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As a result (part of) the observed association between distress disorders and CHD may be 
actually due to the comorbidity with fear disorders.  
The aim of the current study is to examine the association between (any) fear and (any) 
distress disorder with subsequent onset of heart disease, while taking into account the 
temporal order of disorders. We hypothesize that both fear and distress disorders are 
predictors of subsequent onset of heart disease, but the risk associated with pure (non-
comorbid) fear disorder, or fear disorder preceding distress disorder, will be stronger than the 
risk associated with pure (non-comorbid) distress disorder.  
 
Method 
Samples and procedures 
This study used data from 20 of the WMH general population surveys. Most surveys were 
based on nationally representative household samples; the others were representative of urban 
areas (Colombia, Mexico, PRC Shenzhen, Japan).  Interviews took place between 2001 and 
2012 (see table 1). In most countries the interview was divided in two parts to reduce 
respondent burden. All respondents completed Part 1, which included the diagnostic 
assessment of most mental disorders, including fear and distress disorders. All Part 1 
respondents who met lifetime criteria for any mental disorder and a probability sample of 
respondents without mental disorders were administered Part 2 that, among others, assessed 
physical conditions. Part 2 responses were weighted by the inverse of their probability of 
selection into Part 2. Further details about WMH sampling and weighting are available 
elsewhere (Heeringa et al., 2008). 
Analyses in the current study are based on the weighted Part 2 subsample (n= 53,791; person 
years = 2,212,430). Additional weights were used to adjust for differential probabilities of 
selection within households and to match population distributions on socio-demographic and 
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geographic data. Measures taken to ensure data accuracy and cross-national consistency are 
described elsewhere (Kessler & Ustün 2004; Kessler & Ustün 2008).  
 
Ethics statement 
Procedures for human subject protection were approved and monitored for compliance by the 
institutional review boards of the organizations coordinating the surveys. Informed consent 
was obtained before the interviews commenced (Kessler & Ustün 2008). 
Measures 
Mental disorders 
Lifetime history, and age of onset, of DSM-IV mental disorders were assessed using the 
WMH survey version of the WHO Composite Diagnostic Interview (CIDI 3.0) (Kessler & 
Ustün 2004). The interview included probing strategies to increase reliability of the age of 
onset of disorders (Kessler & Ustün 2004). Fear disorders included PD, agoraphobia without 
PD, SAD, specific phobia, and PTSD because of their association with phobic fear and 
somatic arousal (Clark & Watson 1991; Brown & McNiff 2009; Den Hollander-Gijsman et 
al., 2010), which we hypothesized as driving factors for an association with subsequent heart 
disease. Distress disorders included major depressive episode/dysthymia and GAD. 
Respondents were also assessed for obsessive-compulsive disorder, bipolar disorder broad (I, 
II and sub threshold); substance use disorders (alcohol abuse and dependence, drug abuse and 
dependence); and impulse control disorders (intermittent explosive disorder, bulimia nervosa, 
and binge eating disorder). CIDI diagnoses of lifetime history of these mental disorders have 
shown generally good concordance with diagnoses based on blinded clinical interviews (Haro 
et al. 2006).  
Heart disease 
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Lifetime presence of heart disease was assessed from questions adapted from the US Health 
Interview Survey. Respondents were asked whether a doctor or other health professional had 
ever told the participant they suffered from heart disease (“Did a doctor or other health 
professional ever tell you that you had heart disease?”). Respondents were also asked whether 
they ever had a heart attack (“Have you ever had a heart attack”?). If respondents were ever 
told to have heart disease, or responded they ever had a heart attack, they were classified as 
having a history of heart disease. Respondents were asked how old they were when they were 
first diagnosed or had a heart attack and this year was used as age of onset of heart disease (if 
both were endorsed the youngest age was used). Consistent with previous publications on 
associations between mental disorders and various somatic diseases in the WMH surveys 
(Aguilar-Gaxiola et al., 2016; O'Neill et al., 2014; Rapsey et al., 2015; Scott et al. 2011; Scott 
et al. 2013; Swain et al., 2015), only adult-onset heart disease (age ≥ 21 years) was 
investigated in this study in order to exclude cases of childhood onset heart disease.  
Childhood family adversities 
Two previous reports of the WMH surveys showed associations between childhood family 
adversities and somatic conditions (Scott et al. 2008; Scott et al. 2011), which may confound 
the association between fear and distress disorder categories with subsequent heart disease. 
All surveys included questions on physical and sexual abuse occurring within the family 
context before age 18 (details regarding the assessment of these adversities can be found in 
Scott et al. 2008). 
Statistical analysis 
Discrete-time survival analyses (Singer & Willett 1993) with person-year as the unit of 
analysis were used to investigate associations between fear and distress disorder categories 
and the subsequent onset of heart disease. A person-year data set was created in which each 
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year in the life of each respondent up to and including the age of onset of heart disease or their 
age at interview (whichever came first) was treated as a separate observational record, with 
the year of heart disease onset coded 1 and earlier years coded 0 on a dichotomous outcome 
variable. Those reporting heart disease onset before age 21 (n=423, 11.4% of the total number 
reporting heart disease) were excluded from the analyses. Using information on age of onset 
of fear and distress disorder, respondents were categorized in 6 exclusive groups: respondents 
with pure fear disorder, respondents with pure distress disorder, respondents with fear 
disorder preceding distress disorder, respondents with distress disorder preceding fear 
disorder, respondents with a simultaneous onset of fear and distress disorder, and respondents 
with neither a distress nor a fear disorder. Initially all respondents were coded 1 on “no fear 
and no distress” and this variable was switched off one year after onset of the first disorder in 
the other categories, and respondents were coded 1 on their respective category from that 
point in time. This time lag of 1 year ensured that inclusion in the fear or distress categories in 
the same year as heart disease onset did not count as a predictor. Only person-years up to the 
diagnosis of heart disease were analyzed so that only fear or distress episodes occurring prior 
to the onset of heart disease were included in the predictor set. Logistic regression analysis 
was used to estimate associations with the survival coefficients presented as odds ratios, 
indicating the relative odds of heart disease onset in a given year for an individual in a 
specific category compared to individuals with neither a distress nor a fear disorder (reference 
group). When examining whether differences between pure fear disorder and fear preceding 
distress disorder were significantly different from pure distress disorder, we changed the 
reference group to the group consisting of respondents with pure distress disorder.  
Covariates were selected a priori based on the literature and previous reports of the WMH 
surveys. In the first model analyses are adjusted for person-years, country, age-cohorts, and 
gender. The second model additionally adjusted for time-varying education (number of years) 
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and smoking (never/ever/current) since these variables could be confounders in the 
associations between fear and distress disorder categories and subsequent heart disease. In the 
third model, results were additionally adjusted for childhood family adversity. Finally, in the 
fourth model total number of comorbid disorders not included in the fear/distress categories 
(i.e. bipolar disorder, obsessive-compulsive disorder, impulse-control disorders, and substance 
use disorders) was added to the model. We examined whether there were gender differences 
in the association between fear and distress disorders with subsequent heart disease by 
including an interaction term between disorder categories and gender in the first model. 
Consistent with a previous study on WMH data there were no significant interactions (Scott et 
al. 2013) (results not shown, available upon request). It could be hypothesized that differences 
for associations with heart disease exist for disorders on the basis of whether acute fear can be 
avoided (i.e. agoraphobia without PD, social phobia, specific phobia) or not (i.e. PD, PTSD) 
since somatic arousal may be specifically linked to the latter (Brown & McNiff 2009). 
Therefore, in sensitivity analysis, we examined whether respondents with pure phobia and 
pure PD or PTSD were at an increased risk of subsequent heart disease compared with 
respondents without pure PD, pure PTSD, or pure phobia.  
Because the data were clustered and weighted, standard errors were estimated using the 
Taylor series linearization method (Wolter 1985) implemented in the SUDAAN software 
system (11.0) (Research Triangle Institute 2002). Significance tests were all evaluated at the 
0.05 level using two-sided tests. 
Results 
Sample characteristics 
The weighted average response rate across surveys was 69.0%. The characteristics of the 
sample are presented per country in table 1 together with the number of respondents who 
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reported to have heart disease and the (weighted) prevalence of a history of heart disease. This 
prevalence ranged from 1.7% in Peru to 14.2% in Romania. Prevalence of heart disease in the 
total sample was 5.9%.  
Prevalence of fear and distress disorder  
The prevalence of fear disorder was 13.3% (SE: 0.2) and the prevalence of distress disorder 
was 14.0% (SE: 0.2) in the total sample. Table 2 includes prevalence rates of the fear and 
distress disorder categories taking into account comorbidity between fear and distress 
disorders and the temporal order of disorders. Most respondents had pure distress disorder 
(8.5%), followed by respondents with pure fear disorder (7.7%), respondents with fear 
disorder preceding distress disorder (3.8%), respondents with a simultaneous onset of distress 
and fear disorder (0.9%) and respondents with distress disorder preceding fear disorder 
(0.8%).  
Associations between fear and distress disorder categories with subsequent onset of heart 
disease 
After adjusting for person-years, country, age-cohorts and gender (model 1), all categories 
predicted subsequent heart disease (ORs: 1.5-2.0) compared with the category consisting of 
respondents with no distress and no fear disorder (Table 3). Additional adjustment for 
smoking and education (model 2) did not change the results, but after additional adjustment 
for childhood adversity (model 3) the relationship between simultaneous onset of fear and 
distress disorder lost statistical significance. In the final model that further adjusted for 
number of comorbid mental disorders the ORs were attenuated but remained statistically 
significant. ORs were largest for pure fear (OR: 1.8; 95% CI: 1.5-2.2) and fear preceding 
distress disorder (OR: 1.6; 95% CI: 1.4-2.0) and lower for distress disorder preceding fear 
disorder (OR: 1.5; 95% CI: 1.0-2.2) and pure distress disorder (OR: 1.4; 95% CI: 1.2-1.7).  
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After changing the reference group to respondents with pure distress disorder, respondents 
with pure fear disorder were at a significantly increased risk of heart disease (OR: 1.3; 95% 
CI: 1.0-1.6) while the estimates did not reach statistical significance for fear disorder 
preceding distress disorder (OR: 1.2; 95% CI: 0.9-1.5) and distress disorder preceding fear 
disorder (OR: 1.1; 95% CI: 0.7-1.6) (Table 3). 
Subtypes of pure fear disorder and subsequent heart disease 
Table 4 shows results for the sensitivity analysis that examines the association between pure 
PD/PTSD and pure phobia with subsequent heart disease. After adjustment for persons-years, 
country, age-cohorts, education, smoking, and childhood family adversity, both pure 
PD/PTSD (OR: 1.9; 95% CI: 1.5-2.5) and pure phobia (OR: 1.6; 95% CI: 1.4-1.8) were 
significantly related to heart disease.  
Discussion 
The results of this study suggest that fear disorders are more strongly related to the 
development of heart disease than distress disorders. While both fear and distress disorders 
were predictive of subsequent self-reported heart disease after adjustment for 
sociodemographic factors, childhood family adversities and comorbid mental disorders, the 
effect estimates were highest for pure fear disorder and fear preceding distress disorder. When 
compared to pure distress disorder this difference was significant for pure fear disorder, 
although it was not significant for fear preceding distress disorder. However, this may be the 
result of reduced statistical power since the group consisting of individuals with pure fear 
disorder was larger than the group consisting of individuals with fear preceding distress 
disorder.  
Fear disorders, including PD, phobias, and PTSD have an early age of onset (Kessler et al., 
2005) and are generally persistent over time (Kessler et al., 2012b), suggesting that anxious 
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individuals experience long-term exposure to mechanisms potentially leading to heart disease. 
This might explain the stronger adverse relationship of fear disorder with heart disease when 
compared to distress disorder. Fear disorders are further specifically characterized by 
underlying symptom dimensions of somatic arousal and phobic fear. These characteristics 
have been repeatedly shown to predict incident CHD (Albert et al., 2005; Nabi et al., 2010) 
and CHD prognosis (Watkins et al., 2010; Roest et al., 2014), although not all study results 
have been consistent. In a relatively small sample of patients who were assessed for anxiety 
and depression before undergoing coronary artery bypass graft surgery, neither fear disorder 
(a cluster including PD, agoraphobia and SAD) nor anxious arousal was predictive of 
cardiovascular and cerebrovascular events. Only GAD, and not distress disorder (a cluster 
including GAD, major depression, dysthymia and PTSD), was related to the combined 
endpoint (Tully et al., 2015b). Similarly, in the Netherlands Health Survey and Incidence 
Study-2 (NEMESIS-2), Batelaan et al., (2014) examined types of anxiety disorders (worry-
type, panic-type, and phobic-type), and found that only GAD was significantly related to 
incident cardiovascular disease (Batelaan et al., 2014). In contradiction to these findings, in a 
previous study of the WMH surveys GAD was only weakly associated with subsequent heart 
disease (Scott et al., 2013). These conflicting results for GAD could potentially be the result 
of GAD cross loading on both the fear and distress dimension (Eaton et al., 2013).  
Mechanisms 
Our finding that (pure) fear disorder was a stronger predictor of heart disease onset than 
(pure) distress disorder is possibly indicative of a specific link between fear disorders and 
CHD. However, at the moment only preliminary evidence exists for such a specific effect. 
One suggested mediator of the association between somatic hyper arousal and CHD is 
dysregulation of the autonomic nervous system. However, it appears that the association 
between anxiety disorders and reduced heart rate variability is, at least partly, mediated or 
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confounded by the use of antidepressant medications (Licht et al., 2009) and adverse health 
behaviors, such as smoking, alcohol overuse and sleep disturbance (Dennis et al., 2014). 
Since physiological and behavioral factors that may mediate associations between mental 
disorders and heart disease are interdependent, additional research should preferably study 
these factors in networks instead of in isolation (de Jonge & Roest 2012).  
Strengths and limitations 
An important strength of the current study is the use of a theoretical framework to examine 
associations between fear and distress disorders with subsequent heart disease. The use of 
liability dimensions over specific disorders has previously been demonstrated by Eaton et al. 
(2013), who showed that liabilities of distress and fear, and not disorder-specific variation 
predicted health outcomes in a nationally representative sample of the US population. A 
potential limitation of the current study is that our decision to include PTSD as a fear disorder 
may be questionable. Studies examining the structure of mental disorders (e.g. Krueger 1999, 
Vollebergh et al., 2001) often did not include PTSD (Carragher et al., 2015). In other cases, 
PTSD was assigned to the distress category (Cox et al., 2002; Kessler et al., 2012a; Slade & 
Watson 2006). Also, a recent analysis on data from the WMH surveys classified PTSD as a 
distress disorder, although PTSD cross-loaded on both the fear and distress factor (Wardenaar 
et al., in press). Indeed, factor loadings for PTSD have been found to be relatively low (Cox et 
al., 2002; Slade & Watson 2006; Wardenaar et al., in preparation) and it has been 
hypothesized that symptoms of emotional numbing may drive the relationship between PTSD 
and distress disorders (Slade & Watson 2006). We decided to include PTSD in the fear 
category because of its association with somatic arousal (Brown & McNiff 2009), one of the 
specific features we hypothesized to be responsible for the increased risk of heart disease 
onset. It is important that future research further improves the transdiagnostic model of mental 
disorders, not only by including additional disorders, but also other factors associated with 
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psychopathology, such as neurobiological systems and genetic variance (Carragher et al., 
2015; Krueger & Eaton 2015). Another limitation of the current study is that only DSM-IV 
diagnoses were assessed and we could not examine the dimensional aspect of fear and distress 
symptomatology in association with incident heart disease. Combining a dimensional 
approach to psychopathology with information from neurobiological measures is one of the 
main components of the RDoC project, which aims to improve future diagnosis of psychiatric 
disorders (Cuthbert 2014; Kozak and Cuthbert 2016). Other limitations with respect to the 
WMH surveys include the retrospective assessment of mental disorders, which probably led 
to an underestimation of the prevalence of mental disorders and potentially to inaccuracies 
regarding age of onset information (Moffitt et al., 2010; Takayanagi et al., 2014). In addition, 
a subjective measure of heart disease (self-report of physician-diagnosed heart disease and 
self-report of heart attack) was used, which may have introduced misclassification of patients 
regarding our endpoint. However, in general, individuals are more likely to accurately report 
medical conditions than mental disorders (Takayanagi et al., 2014). Further, although 
symptoms of fear disorder overlap with symptoms of heart disease disease, and individuals 
with GAD may be more likely to worry about heart disease, individuals were asked whether 
they received a diagnosis of heart disease, which probably reduced over reporting of the 
condition in anxious individuals. Therefore, we do not expect this to account for our 
observation that fear disorders are more strongly associated with heart disease than distress 
disorders, especially since GAD was included in the distress disorder category. Furthermore, 
although we used survival analysis based on age of onset information, our data was cross-
sectional, and future prospective studies are needed to confirm our findings. Future research 
should also replicate the difference between the associations between (pure) fear and (pure) 
distress disorder with heart disease since effect sizes were not very large. Finally, in this study 
only self-report of physician-diagnosed heart disease and self-report of heart attack, and not 
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cardiac mortality could be examined as an endpoint. Since previous studies found a 
relationship between symptoms of phobic anxiety and ventricular arrhythmias and sudden 
cardiac death (Albert et al., 2005; Watkins et al., 2010) the results reported for fear disorders 
are likely to be conservative.   
Clinical implications 
Anxiety has been proposed as a target for primary prevention of CHD (Thurston et al., 2013). 
The current study suggests that particularly individuals with (pure) fear disorders could 
potentially benefit from psychiatric treatment in terms of CHD onset and progression. Various 
treatments options are available for individuals suffering from fear disorders, the most well-
known ones being pharmacological treatment (Roest et al., 2015) and cognitive behavior 
therapy (Hoffman & Smits 2008), which could be offered in a collaborative care framework 
(Huffman et al., 2014). However, before designing trials aimed at improving cardiac risk 
factors in anxious individuals using anxiety treatments, more research is arguably needed to 
study characteristics of the subgroup of individuals who are most at risk of incident CHD and 
ideally mechanisms involved in this association should be identified.   
Conclusions 
The main finding of this study was that dividing anxiety and depressive disorders into fear 
and distress disorder, while taking the temporal order of disorders into account, provided 
important information regarding the association of these conditions with subsequent self-
report of physician-diagnosed heart disease or self-report of heart attack. While most disorder 
categories were related to development of heart disease, the risk was significantly higher for 
individuals with fear disorder only, compared with individuals with distress disorder only. 
Our findings thus suggest that the focus on depression in the context of heart disease should 
be extended to fear disorders. This attention is warranted in order to examine which 
 18 
mechanisms are more strongly activated in the case of fear compared with distress, or whether 
specific mechanisms exist that link fear disorder to the development of heart disease. 
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